The neural androgen receptor: a therapeutic target for myelin repair in chronic demyelination.

@article{Hussain2013TheNA,
  title={The neural androgen receptor: a therapeutic target for myelin repair in chronic demyelination.},
  author={Rashad Hussain and Abdel M Ghoumari and Bartosz Bielecki and J{\'e}r{\^o}me Steibel and Nelly Boehm and Philippe Li{\`e}re and Wendy B Macklin and Narender Kumar and Ren{\'e} Habert and Sakina Mhaouty-Kodja and François Tronche and R{\'e}gine L Sitruk-Ware and Michael Schumacher and M. Said Ghandour},
  journal={Brain : a journal of neurology},
  year={2013},
  volume={136 Pt 1},
  pages={132-46}
}
Myelin regeneration is a major therapeutic goal in demyelinating diseases, and the failure to remyelinate rapidly has profound consequences for the health of axons and for brain function. However, there is no efficient treatment for stimulating myelin repair, and current therapies are limited to anti-inflammatory agents. Males are less likely to develop multiple sclerosis than females, but often have a more severe disease course and reach disability milestones at an earlier age than females… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 5 times over the past 90 days. VIEW TWEETS
28 Citations
68 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 28 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 68 references

In vitro and in vivo models of multiple sclerosis

  • BJ van der Star, DY Vogel, M Kipp, F Puentes, D Baker, S. Amor
  • CNS Neurol Disord Drug Targets
  • 2012
2 Excerpts

Similar Papers

Loading similar papers…